¡Ya estamos en !
Descubre más
Vincerx Pharma
Dejó de cotizar
VINC dejó de cotizar en bolsa el 22 de abril de 2025.
Acerca de: Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.
Empleados: 13
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
0%
Neutral
0%
Negativo
0%
Gráficos de precios implementados con Lightweight Charts™